1. Home
  2. SHFS vs RVPH Comparison

SHFS vs RVPH Comparison

Compare SHFS & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHFS
  • RVPH
  • Stock Information
  • Founded
  • SHFS 2015
  • RVPH 2006
  • Country
  • SHFS United States
  • RVPH United States
  • Employees
  • SHFS N/A
  • RVPH N/A
  • Industry
  • SHFS Finance: Consumer Services
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHFS Finance
  • RVPH Health Care
  • Exchange
  • SHFS Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • SHFS 36.1M
  • RVPH 36.4M
  • IPO Year
  • SHFS N/A
  • RVPH N/A
  • Fundamental
  • Price
  • SHFS $0.69
  • RVPH $1.20
  • Analyst Decision
  • SHFS
  • RVPH Strong Buy
  • Analyst Count
  • SHFS 0
  • RVPH 3
  • Target Price
  • SHFS N/A
  • RVPH $14.33
  • AVG Volume (30 Days)
  • SHFS 70.6K
  • RVPH 165.3K
  • Earning Date
  • SHFS 08-12-2024
  • RVPH 08-12-2024
  • Dividend Yield
  • SHFS N/A
  • RVPH N/A
  • EPS Growth
  • SHFS N/A
  • RVPH N/A
  • EPS
  • SHFS N/A
  • RVPH N/A
  • Revenue
  • SHFS $17,433,323.00
  • RVPH N/A
  • Revenue This Year
  • SHFS N/A
  • RVPH N/A
  • Revenue Next Year
  • SHFS N/A
  • RVPH N/A
  • P/E Ratio
  • SHFS N/A
  • RVPH N/A
  • Revenue Growth
  • SHFS 45.42
  • RVPH N/A
  • 52 Week Low
  • SHFS $0.33
  • RVPH $1.05
  • 52 Week High
  • SHFS $1.55
  • RVPH $6.80
  • Technical
  • Relative Strength Index (RSI)
  • SHFS 57.47
  • RVPH 39.35
  • Support Level
  • SHFS $0.61
  • RVPH $1.17
  • Resistance Level
  • SHFS $0.74
  • RVPH $1.35
  • Average True Range (ATR)
  • SHFS 0.06
  • RVPH 0.10
  • MACD
  • SHFS 0.02
  • RVPH 0.03
  • Stochastic Oscillator
  • SHFS 77.65
  • RVPH 48.33

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: